Menu Back toS46-Establishing-Real-World-Evidence-in-Japan-from-the-Perspective-of-Database-Utilization

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe


[S46] Establishing Real-World-Evidence in Japan, from the Perspective of Database Utilization

Session Chair(s)

Koji  Kawakami, MD, PhD

Koji Kawakami, MD, PhD

  • Professor and Chair, Department of Pharmacoepidemiology
  • Graduate School of Medicine and Public Health, Kyoto University, Japan
Real-world-evidence(RWE) has become more important, in association with increasing recognition of value-based-medicine or healthcare. In Japan, the healthcare industry, government and academia are making great efforts to establish various databases or patient registries to be utilized for clinical development, pharmacovigilance or research purpose. However, RWE in Japan is still very much behind compared with those of western countries. The purpose of this session is to discuss how to promote RWE generation in Japan, especially from the perspective of utilization of database. The overviews of RWE in Japan or other countries will be provided. Also, the speaker from Japanese pharmaceutical industry will share recent experience of RWE generation.

Speaker(s)

Koji  Kawakami, MD, PhD

The Largest Clinical RWD Database Development in Japan - Overview and Future Opportunities

Koji Kawakami, MD, PhD

  • Professor and Chair, Department of Pharmacoepidemiology
  • Graduate School of Medicine and Public Health, Kyoto University, Japan
Eiko  Shimizu, PhD, MSc

RWD frontline: Expectation for RWD and its limitation in Japan

Eiko Shimizu, PhD, MSc

  • Project Lecturer, Pharmaco-Business Innovation, Graduate School of Phama Science
  • The University of Tokyo, Japan
Toshinaga  Tsuji, PhD

Work Productivity and Disease Burden in Patients with Pain Using Japanese Web Survey

Toshinaga Tsuji, PhD

  • Scientific Leader (CNS), Medical Affairs
  • Shionogi & Co., Ltd, Japan
Nancy A. Dreyer, PhD, MPH, FISPE

Growing Regulatory Use of RWE Outside of Japan

Nancy A. Dreyer, PhD, MPH, FISPE

  • Chief Scientific Officer and Senior Vice President
  • IQVIA, United States